Filing excerpt
In October, the FDA approved the PASCAL Precision system for tricuspid regurgitation, expanding access to this important therapy for patients.
Source: Autobound Signal API · 68 signals tracked for Edwards Lifesciences · updated
Get Edwards Lifesciences' live signals in Claude or ChatGPT, or by API
What changed at Edwards Lifesciences this week? Use Autobound signals for edwards.com.Edwards Lifesciences received U.S. FDA approval for the PASCAL Precision system for tricuspid regurgitation and PASCAL Ace with Capture Clarity for degenerative mitral TEER procedures, initiating measured rollouts.
Filing excerpt
In October, the FDA approved the PASCAL Precision system for tricuspid regurgitation, expanding access to this important therapy for patients.
What this signalsFilings often name leadership changes, deals and spending plans.
Technologies
Regions named
sec-8kproductLaunchGet every 8-K signal for Edwards Lifesciences and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Edwards Lifesciences this week?”
The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/9a2a46fa-f935-4715-afe2-2d4b68173a36 returns this record as JSON. POST /v1/companies/enrich returns every signal for edwards.com.
{
"signal_id": "9a2a46fa-f935-4715-afe2-2d4b68173a36",
"signal_type": "sec-8k",
"signal_subtype": "productLaunch",
"detected_at": "2026-11-10T07:04:15.822+00:00",
"company": {
"name": "Edwards Lifesciences",
"domain": "edwards.com"
},
"data": {
"detail": "Edwards Lifesciences received U.S. FDA approval for the PASCAL Precision system for tricuspid regurgitation and PASCAL Ace with Capture Clarity for degenerative mitral TEER procedures, initiating measured rollouts. This expansion in commercial therapies may drive demand for clinical training, commercial enablement, and specialized surgical and hospital-provider engagement tools.",
"metrics": {
"timeframe": "current_quarter"
},
"summary": "FDA Approves PASCAL Precision for Tricuspid and PASCAL Ace with Capture Clarity",
"excerpts": "In October, the FDA approved the PASCAL Precision system for tricuspid regurgitation, expanding access to this important therapy for patients.",
"relevance": 0.8,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1099800/000109980026000053/ew-20261104.htm",
"filing_date": "2026-11-04",
"filing_year": 2026,
"fiscal_year_end": "11/04",
"sales_relevance": "Go-to-market support",
"signal_category": "strategic",
"regions_mentioned": [
"U.S."
],
"technologies_mentioned": [
"Capture Clarity"
]
}
}
curl https://signals.autobound.ai/v1/signals/9a2a46fa-f935-4715-afe2-2d4b68173a36 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"edwards.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.